secwatch.observer — SEC 8-K summary
======================================

Issuer:     BioCardia, Inc. (BCDA)
CIK:        0000925741
Form:       8-K
Filed at:   2025-12-03T23:59:59+00:00
Accession:  0001437749-25-036711
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 5.07, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BioCardia elects Marvin Slosman to board; Dr. Richard Krasno completes term
---------------------------------------------------------------------------

- Marvin Slosman, CEO of InspireMD, elected to BioCardia board effective Dec. 2, 2025.
- Dr. Richard Krasno, a director since 2016, completed his term and departed the board on Dec. 2, 2025.
- At the annual meeting, shareholders elected Slosman, Jay M. Moyes, and Simon H. Stertzer as Class III directors.
- Shareholders also approved amendment to 2016 Equity Incentive Plan extending term to 2035 and increasing share reserve.
- Ratification of PKF San Diego as auditor approved; advisory vote on executive compensation passed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/925741/000143774925036711/0001437749-25-036711-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/925741/000143774925036711/bcda20251202_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-036711

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer